Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 32 n° 250

Posts Tagged ‘tricida’

Tricida to Host Investor Day

Posted by fidest press agency su lunedì, 7 ottobre 2019

Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today that it will host its inaugural Investor Day on October 15, 2019 from 8:30 a.m. to 11:30 a.m. Eastern Time in New York, NY.The Tricida management team will provide a comprehensive overview of the Company’s commercialization strategy and market opportunity for veverimer in the treatment of metabolic acidosis in patients with CKD.
Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD). Tricida has submitted a New Drug Application seeking approval of veverimer through the U.S. Food and Drug Administration’s Accelerated Approval Program, and is currently conducting its confirmatory postmarketing trial, VALOR-CKD.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »